An analyst from Morgan Stanley initiated coverage of Edwards Lifesciences (NYSE: EW) at 'overweight' with a price target of $102.00. Prior to this rating, Edwards Lifesciences had 13 buy...
An analyst from Truist Securities maintained Edwards Lifesciences (NYSE: EW) at 'buy' with a price target of $101.00 from a prior price target of %currency%%price%. Prior to this rating,...
A Barclays analyst maintained Edwards Lifesciences (NYSE: EW) at Overweight and a price target of $102.00 from a prior price target of %currency%%price%. Prior to this rating, Edwards...
A RBC Capital analyst maintained Edwards Lifesciences (NYSE: EW) at Outperform and a price target of $96.00 from a prior price target of %currency%%price%. Prior to this rating, Edwards...
Edwards Lifesciences (NYSE:EW) reported its {{erl-13794||Q1 results, with both EPS of $0.62 and revenues of $1.46 billion (up 9% year-over-year) coming in above the consensus estimates of...
Investing.com - Edwards Lifesciences (NYSE: EW) reported first quarter EPS of $0.62, $0.01 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.46B versus the...
A Mizuho Securities analyst maintained Edwards Lifesciences (NYSE: EW) at Buy and a price target of $95.00 from a prior price target of %currency%%price%. Prior to this rating, Edwards...
A Truist Securities analyst maintained Edwards Lifesciences (NYSE: EW) at Buy and a price target of $93.00 from a prior price target of %currency%%price%. Prior to this rating, Edwards...
A Citi analyst maintained Edwards Lifesciences (NYSE: EW) at Buy and a price target of $97.00. Prior to this rating, Edwards Lifesciences had 13 buy ratings, 13 hold ratings, and 1 sell...
An UBS analyst initiated new coverage Edwards Lifesciences (NYSE: EW) Neutral rating and a price target of $84.00. Prior to this rating, Edwards Lifesciences had 13 buy ratings, 13 hold...
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the analysts’ biggest negative rating moves you may have missed on InvestingPro. Start your free 7-day trial to get...
By Sam Boughedda Edwards Lifesciences (NYSE:EW) was cut to Equal Weight from Overweight by Wells Fargo analysts, who also lowered the firm's price target on the stock to $78 from $97 on...
By Michael Elkins Raymond James downgraded Edwards Lifesciences Corp (NYSE:EW) to a Market Perform rating (From Outperform) as confidence in the company’s growth profile begins to fade. EW’s...
By Davit Kirakosyan Wolfe Research downgraded World Wrestling Entertainment (NYSE:WWE) to Peer Perform from Outperform and removed the $111 price target. Shares are up about 25% since...
Edwards Lifesciences (EW) reported Q4 EPS of $0.64, $0.03 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.33...
Investing.com - Edwards Lifesciences (NYSE: EW) reported fourth quarter EPS of $0.64, $0.03 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.35B versus the...
By Sam Boughedda Bernstein analysts double downgraded Edwards Lifesciences (NYSE:EW) to Underperform from Outperform on Tuesday, cutting the firm's price target on the stock to $66 from $95...
By Davit Kirakosyan Baird downgraded Boot Barn (NYSE:BOOT) to Neutral from Outperform with a price target of $86.00, noting that the company’s {{erl-942484||Q3 report last week...
By Sam Boughedda In a research note Monday, Piper Sandler analysts downgraded Edwards Lifesciences (NYSE:EW) to Neutral, lowering the firm's price target on the stock to $80 from $95 per...
By Investing.com Staff After five days of selling pressure, stocks finally snapped the streak today following a rise in jobless claims. Amid the upside, several rumors swirled around Wall...
By Investing.com Staff Stocks edged lower on Monday but finished the month sharply higher, with the Dow rising 14% in October. Amid today's downside action, several rumors drove trading...
After-Hours Stock Movers: Amazon.com (NASDAQ:AMZN) 14% LOWER; {{erl-6435||reported Q3 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $127.1...
Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter {{erl-13794||earnings that missed analysts' expectations on Thursday and revenue that fell short of forecasts. The...
Edwards Lifesciences (EW) reported Q3 EPS of $0.61, $0.01 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.33...
By Sam Boughedda Edwards Lifesciences (NYSE:EW) shares have fallen over 6% Friday on the back of its earnings release. The {{erl-13794||company reported after the close Thursday, missing...
Pre-Open Stock Movers: Roku (NASDAQ:ROKU) 26% LOWER; {{erl-1050149||reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4...
After-Hours Stock Movers: {{erl-1050149||Roku (NASDAQ:ROKU) 25% LOWER; reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4...
Investing.com - Edwards Lifesciences (NYSE:EW) reported second quarter {{erl-13794||earnings that missed analysts' expectations on Thursday and revenue that fell short of forecasts. The...
Edwards Lifesciences (NYSE:EW) reported Q2 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of...
By Daniel Shvartsman Investing.com - Central Banks and earnings will continue to dominate the week ahead. After the European Central Bank announced an unexpectedly hawkish 50 basis point...
Investing.com - Edwards Lifesciences (NYSE:EW) reported first quarter {{erl-13794||earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts. The firm reported...
Edwards Lifesciences (NYSE:EW) reported Q1 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of...
By Sam Boughedda Investing.com -- Shares of Edwards Lifesciences Corp (NYSE:EW) fell Monday after Evercore ISI analyst Vijay Kumar added the stock to the firm's Tactical Underperform...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Telecoms, Utilities and Basic Materials sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com - Edwards Lifesciences (NYSE:EW) reported fourth quarter {{erl-13794||earnings that missed analysts' expectations on Wednesday and revenue that fell short of forecasts. The...
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Basic Materials, Oil & Gas and Technology sectors propelled shares higher while losses in the Utilities,...
Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter {{erl-13794||earnings that beat analysts' expectations on Wednesday and revenue that fell short of forecasts. The firm...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Healthcare, Utilities and Oil & Gas sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Technology, Consumer Services and Healthcare sectors propelled shares lower. At the close in NYSE, the Dow...
Investing.com - Edwards Lifesciences (NYSE:EW) reported second quarter {{erl-13794||earnings that beat analysts' expectations on Thursday and revenue that topped forecasts. The firm...
Investing.com - Edwards Lifesciences (NYSE:EW) reported first quarter {{erl-13794||earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts. The firm reported...
Investing.com - Edwards Lifesciences (NYSE:EW) reported fourth quarter {{erl-13794||earnings that missed analysts' expectations on Wednesday and revenue that was inline with forecasts. The...
Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter {{erl-13794||earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts. The firm...
By Geoffrey Smith Investing.com -- Tesla (NASDAQ:TSLA) reports earnings as the quest for a compromise on a stimulus package overruns the House's self-imposed deadline. The dollar and bonds...
By Christiana Sciaudone Investing.com -- Will we hear the last of the stimulus debate soon? Here's hoping. Markets were higher with House Speaker Nancy Pelosi optimistic over getting a...
Investing.com - Edwards Lifesciences (NYSE:EW) reported second quarter {{erl-13794||earnings that beat analysts' expectations on Thursday and revenue that topped forecasts. The firm...
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Financials, Telecoms and Basic Materials sectors propelled shares higher while losses in the Utilities,...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
